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Summary.-The cytotoxic effects in vivo of hydroxyurea (HU) on murine fibrosar-
coma (FSa) cells grown as pulmonary tumours were determined. Tumour cells
from 13-day-old nodules were made into suspension and separated on the basis
of cell size by centrifugal elutriation. Flow microfluorometry (FMF) was used to
determine the cell-cycle parameters and the relative synchrony of the separated
populations, as well as the degree of contamination by normal diploid cells in each
of the tumour-cell populations. HU cytotoxicity was tested by administering both a
single 1mg/g i.p. dose into mice that had been injected i.v. 20 min earlier with known
numbers of synchronized viable FSa cells, and i.p. doses of 1 mg/g each into mice
bearing 13-day-old pulmonary nodules. In the latter experiments, animals were
killed 1 h after the last dose, and the tumour nodules were excised and made into a
single-cell suspension and elutriated. Known numbers of cells from each fraction
were injected into recipient mice to determine survival. In both sets of experiments,
cell killing by HU correlated with the percentage of S-phase cells. The treatment
of 13-day-old pulmonary nodules with 3 doses of HU also depleted the (G2+M)
phase tumour cells and increased the heterogeneity between tumour subpopulations,
as determined by FMF analysis.
MANY OF THE CHEMICAL AGENTS cur-
rently used in cancer therapy have
phase-specific cytotoxicity. To evaluate
these agents better before clinical trials,
it would be advantageous to characterize
their effectiveness on synchronized target
cells within living animals. Recently, an
in vivo method of studying the cell-cycle
phase specific effects of a variety of
chemotherapeutic agents in vivo was
described (Grdina etal., 1979, 1980). Target
tumour populations, enriched with cells
in either G1, S or G2 +M phase by centri-
fugal elutriation, were injected i.v. into
mice 20 min before the i.v., i.p., or s.c.
administration of the drug to be tested.
With the appropriate controls, the phase-
specific cytotoxicity of any test agent
could be determined (Grdina et al., 1979).
A limitation of this procedure, however,
wastheneedforthe inherentheterogeneity
of the tumour-cell populations derived
from solid tumours to be reduced for cell
separation by centrifugal elutriation to
be effective (Anderson et al., 1969;
Grdina et al., 1978b). This was accom-
plished by a 48h in vitro incubation
(Grdina et al., 1978a). To avoid this
limitation, the method of centrifugal
elutriation has been applied to separate
murine fibrosarcoma (FSa) cells from
pulmonary tumour nodules grown in
C3H mice. Hydroxyurea (HU), because
of its well characterized S-phase-specific
cytotoxicity (Kim et al., 1967; Sinclair,
1967), was chosen to demonstrate the
applicability of this procedure to charac-
terizing the in vivo effectiveness of
phasespecific chemotherapeutic agents on
advanced metastatic disease.
MATERIALS AND METHODS
Mice and tumour.-Female C3Hf/Kam
mice, 10-12 weeks old, from our specific-IN VIVO CYTOTOXICITY OF HYDROXYUREA
pathogen-free breeding colony and a methy-
cholanthrene-induced fibrosarcoma were used
(Suit & Suchato, 1967). Tumours, 6th-
generation isotransplants, were made into
viable single-cell suspensions and injected
into untreated recipient mice to produce
100-150 pulmonary nodules (Grdina et al.
1978b). After 13 days, tumour-bearing
animals were killed, either immediately
or after treatment with multiple doses
of HU. Tumour cells derived from these
pulmonary nodules were used in all the
experiments.
Tumour-cell suspension.-Single-cell sus-
pensions were prepared by mincing and
trypsinizing colonies of tumour cells from
excised lungs (Grdina et al., 1979). Because
no advantage was found from the careful
excision of individual tumour nodules from
surrounding lung tissue, cell suspensions
were routinely made from entire lung lobes
containing tumour tissue. Briefly, lung lobes,
separated and removed from the surrounding
viscera, were carefully minced with ophthal-
mic scissors. The mince, containing normal
and tumour tissue, was added to a beaker
containing 0.025% trypsin in Solution A
(8.0g NaCl, 0-4g KCI, I Og glucose and
0 35 g NaHCO3 in a litre of water) and
stirred on a magnetic stirrer for 20 min at
room temperature. DNase (crude Deoxyribo-
nuclease 1 from beef pancreas; Sigma
Chemical Co., St Louis, MO) was also added
to the mixture to achieve a final concentra-
tion of 0 1 mg/ml. After stirring, the beaker
was allowed to stand undisturbed for 5 min.
Highly enriched undigested tumour tissue
settled to the bottom of the beaker, whereas
most of the lung tissue floated to the top.
While exercising care to avoid collecting
floating lung tissue, the upper two-thirds
of the suspension was removed and mixed
with an equal volume of a modified McCoy's
5A growth medium supplemented with 20%
foetal calf serum (Humphrey et al., 1970).
The stirring and collection procedure was
repeated x 3. Each resultant suspension
was passed through a stainless-steel mesh
(200 wires/inch) and centrifuged at 225 g
for 5 min. The supernatants were discarded,
and the pellets were resuspended in McCoy's
5A supplemented with 5% FCS containing
DNase at a final concentration of 0 1 mg/ml.
Also included was 5mM 2-napthol 6-8 di-
sulphonic acid to reduce cell clumping
(Shortman, 1973). After centrifugal elutria-
tion, cell viability was Loutinely >95% as
determined by phase-contrast microscopy.
Separation by centrifugal elutriation.-
FSa cells derived from pulmonary nodules
were separated under sterile conditions by
centrifugal elutriation using the same pro-
cedure described for their separation from
either solid tumours or tissue culture (Grdina
et al., 1978a, 1979). With the rotor speed set
at 1525 rev/min, 2-3 x 108 cells, suspended
in 20 ml ofmedium, were introduced into the
elutriator chamber at a flow rate of 5 4
ml/min. The rotor speed was held constant
throughout the separation, and the flow
rates were varied by equal increments from
5*4 to 27-4 ml/min. Routinely, 12 fractions
(F), each of 50 ml, were collected and stored
at 4°C. Cells collected in each fraction were
counted by haemacytometer and by Coulter
Counter (model ZB1; Coulter Electronics,
Hialeah, FL), and their volume distributions
determined with a multichannel analyser
(Channelyzer II; Coulter Electronics). The
modal volume was designated as that
corresponding to the modal channel number
of the volume distribution of each sample
(Grdina et al., 1978a). F 1 containing small
cells and cellular debris, and F 11 and 12,
containing a heterogeneous mixture of cells,
were discarded.
Flow microfluorometry. The DNA content
of individual cells in suspension was deter-
mined by FMF using an ICP 11 flow cyto-
meter (Phywe Co., Gottingen, Germany).
cells were fixed in 70% ethanol and then
stained with 50 mg/ml mithramycin (Mi-
thracin; Pfizer and Co., Inc., New York,
NY) in solution with MgCl2 (7 5 mM) and
12.5% aqueous ethanol (Grdina et al.,
1978a). The resultant histograms of DNA
fluorescence were computer-analysed (John-
ston et al., 1978). Because cell suspensions
were derived directly from FSa lung nodules,
a considerable number of normal diploid
lung cells were present in all the elutriator
fractions. Since FSa cells are heteroploid
(i.e., 60-70 chromosomes) and contain 1-8
as much DNA as normal diploid cells
(Grdina et al., 1977), an estimate ofthe normal
cell contamination in each of the tumour-
cell suspensions can be made by determining
the area under the G1 normal diploid peak
and dividing it by the area under the total
FMF histogram (i.e., the area under both the
tumour and normal peaks) (Grdina et al.,
1978a). While the relative proportions of
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normal cells in the S and G2+M phases
contaminating FSa tumour-cell suspensions
are uncertain (i.e., fluorescence from these
cells would be detected at the same channels
as those from G1 tumour cells), they are
considered to be sufficiently rare in this
experimental system to be ignored in these
calculations. FMF histograms of lung cells
from tumour-free animals indicate that less
than 2% of the cells are in S or G2+M
phases (unpublished data). Likewise, few
if any diploid cells appear to be in the S
phase in suspensions from pulmonary nodules
(i.e., low background fluorescence in Channels
60 to 80, see Figs. 2 & 6). Therefore all cell
counts were adjusted after FMF analysis
to represent only tumour-cell numbers.
Lung colony assay.-The colony-forming
efficiency (CFE) of FSa cells was determined
in a lung colony assay. Recipient mice, with
their hind legs shielded, were whole-body-
irradiated with 10 Gy 24 h before use.
These mice were then injected with known
numbers of viable FSa cells, corrected for
normal-cell contamination, from each of the
elutriator fractions and the unseparated
control (USC.) population. Each aliquot of
cells also contained 2 x 106 heavily irradiated
(HIR; 100 Gy) FSa cells. HIR cells were
not separated by centrifugal elutriation.
Thirteen days alter the mice were killed,
their lungs were removed, and the lobes
separated and fixed in Bouin's solution, and
tumour colonies counted.
HU testing in vivo.-HU (manufactured
by Ben Venue Laboratories, Bedford, OH)
was obtained from the Division of Cancer
Treatment, National Cancer Institute,
National Institutes ofHealth, Bethesda, MD.
Stock solutions were made up at 100 mg/ml
in sterile water. Two procedures, designated
A and B, were followed to test HU's effective-
ness in vivo. At least 3 replicate experiments
were performed using each procedure. In
procedure A, FSa cells grown as pulmonary
nodules wereharvested, made into suspension,
and separated by centrifugal elutriation
before drug treatment according to the
method described earlier (Grdina et al., 1979).
Twenty minutes after the injection of viable
synchronized FSa cells, 10 of the 20 animals
in each group were injected i.p. with a single
dose of HU at 1I0 mg/g body wt. Thirteen
days later the animals were killed, and the
resulting colonies were counted. In Procedure
B, mice bearing 13-day-oldpulmonary nodules
were injected i.p. each hour with 1 mg/g
HU for 3 h (i.e., total dose 3 mg/g). One hour
after the last injection, the animals were
killed and their lungs removed. Suspensions
of tumour cells were made and separated
by centrifugal elutriation. The CFE of these
cells was determined in a lung-colony assay
with preconditioned mice.
RESULTS
The recovery of cells from centrifugal
elutriation was routinely > 90% and the
viability of these cells, determined by
phase-contrast microscopy, was > 9500.
Fig. 1 shows a representative sedimenta-
tion profile of the relationship between
modal cell volume and the number of
cells recovered in each elutriator fraction.
Analysis of the DNA histograms for each
separated population enabled the distri-
bution of tumour cells with respect to
DNA content to be determined (Fig. 2).
The average sedimentation velocity of
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FIG. 1. Separation of FSa tumour cells
from lung metastasis by centrifugal
elutriation. The percentage of total cells
(0 *), the FMF corrected percentage
of tumour cells only (O-- 0), and the
modal cell volume (A ---A) are plotted
as a function of sedimentation velocity
and fraction nuimber.
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FIG. 2 Representative DNA histograms
obtained by FMF analysis of an un-
separated lung and tumour-cell suspension
(USC) and fractions of cells separate(I
from that suspension by centrifugal
elutriation (F2 - F10). Normal diploid G1 =
G1(N), tumour Ga =Gj(T); and tumour
G2 =G2 +M(T).
these cells was 11 4 mm/h/g, and their
average modal volume was 1250 ,um3.
The percentage of normal diploid G,
cells and tumour G1, S and (G2+M) cells,
and the coefficients of variation (CV)
of the tumour G1 fluorescence peaks, as
calculated from the histograms in Fig. 2,
are presented in Table I. In contrast to
results with tumour cells cultured in vitro
for 48 h (Grdina et al., 1979) normal cell
populations were observed in all elutriator
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FIG. 3.-The colony-forming efficiency
(CFE) of FSa cells separated by centri-
fugal elutriation from lung metastasis.
The CFE uncorrected (A A) and
corrected (0 O) for contaminating
normal diploid cells (as determined by
FMF analysis) is plotted as a function of
fraction number. Each vertical bar
represents + s.e.
fractions, with the largest percentage of
normal diploid cells in F 2.
The CFE of recovered cells, both
uncorrected and corrected for normal
diploid cell contaminationbyFMFanalysis,
is presented in Fig. 3. The average
modal volumes of cells collected in F
2 and 3 were <800 ,um3. The CFE of
tumour cells collected in these fractions,
even after FMF correction for diploid
cells, was significantly less than for cells
in the other fractions.
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TABLE I.-Distribution of untreated cells in various phases of the cell cycle after centri-
fugal elutriation (Determined by FMF analysis)
% Cellls in
Fraction , A_ _
Number G1(N)* Gi(T)t S(T) G2+M(T) CV ofGi(T) peak
Usc 21 65 18 17 4*1
2 46 91 9 0 3-2
3 26 86 11 3 1-4
4 14 81 16 3 3- 8
5 13 73 24 3 4 0
6 10 27 43 30 4-4
7 15 17 37 46 4-5
8 15 16 19 65 4 6
9 14 12 17 71 6*0
10 12 18 16 66 5-8
* G1 of normal diploid cells.
t Gi of tumour cells.
The cell-killing of a single dose of HU
on FSa cells lodged in the lungs of test
animals (i.e., Procedure A) is presented
in Fig. 4. The CFE of both the control
and treated populations was routinely
corrected for normal-diploid-cell con-
tamination. Cell killing with HU was
most evident for FSa cells collected in
F 6 and 7. These fractions contained
the greatest concentrations of cells with
S-phase DNA content. These data are
consistent with the results using cultured
FSa cells (Grdina et al., 1979).
The cytotoxicity of 3 equal in vivo
doses of HU at hourly intervals to FSa
lung-nodule cells (i.e., Procedure B) is
shown in Fig. 5. Animals were killed 1 h
after the last dose, lungs were removed
and made into a single-cell suspension,
and cells were separated by centrifugal
elutriation. DNA histograms describing
the separated tumour populations follow-
ing HU treatment are presented in Fig. 6.
Whereas the fluorescence peaks repre-
senting normal diploid G1 cells remained
unperturbed and comparable to those of
untreated populations (Fig. 2), those
representing HU-treated G1 and (G2+M)
tumour cells are broader and more
heterogeneous. Nevertheless, cell killing
again correlated with the percentage of
cells in S (see Fig. 5). A significant
reduction in the percentage of cells with
(G2+M) DNA content was also found
after this treatment, which is not sur-
prising since the total treatment time was
4 h, and the duration of G2 +M FSa cells
in vivo is only 2-8 h (Grdina, 1982). The
percentages of normal diploid G1 and
tumour G1, 5, and (G2+M) cells, and the
CVs of the G1 tumour fluorescence peaks
are contained in Table II.
DISCUSSION
Although centrifugal elutriation has
been successfully used to separate and
isolate populations of FSa tumour cells
enriched in G1, S or (G2+M) phases
following growth in vitro (Grdina et al.,
1978b, 1979) it has not been effective for
synchronizing FSa cells derived directly
from solid tumours growinginvivo (Grdina
et al., 1977, 1978b). The cellular parameter
that is exploited using this procedure
is cell volume, because the sedimentation
rate of a cell is proportional to the two-
thirds power of its volume (Glick et al.,
1971). Cell size, under conditions of
uniform growth, is known to increase
during the division cycle (Anderson et al.,
1969). Thus, after exponential growth
in vitro, the relationship between cell
size and DNA content is readily exploit-
able for FSa tumour cells. In contrast,
cells growing in solid tumours are exposed
to a variety of physiological conditions,
including variations in the availability of
nutrients,02tensionandpH. Consequently
tumour cells of various sizes can have
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similar DNA contents, making separation
of cell populations on the basis of cell
size ineffective (Sigdestad & Grdina,
1981). Although FSa cell populations from
pulmonary nodules are also more hetero-
geneous than those from exponentially
growing cultures in vitro, they are con-
siderably less so than those from solid
tumours, which is not surprising since
the variations in the microenvironment in
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FiG. 5.-The percentage of surviving FSa
cells after exposure in vivo as 13-day-old
lung no(lules to 3 doses of lhydroxyurea
(HU) (see Procedure B) (above) and the
pereentage of cells distribute(d among the
various cell-cycle phases (below) are each
plotted as a function of fraction number.
Data are from a representative experi-
ment. Symbols as in Fig. 4.
solid tumours are, presumably, considera-
bly greater than those in the smaller
lung-tumour nodules. Biological para-
meters that appear to reflect this "inter-
mediate" situation include a modal cell
volume of 1250 tm3 and an average
sedimentation velocity of 11P4 mm/h/g
for FSa cells from pulmonary nodules,
compared to modal volumes of 980 and
1620 ,tm3 and sedimentation velocities
of 10-7 and 151 mm/h/g for FSa cells
from solid tumours and in vitro cultures,
respectively (Grdina et al., 1978a). These
differences cannot be explained solely
by variations in the cell-cycle distribution
of each of these populations; since FSa
cell suspensions from pulmonary nodules
and solid tumours exhibit similar DNA
histograms by FMF analysis (Grdina et al.,
1977, 1978a).
Little if any variation in CFE or
contamination with normal cells was
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FIG. 6.-Representative DNA histograms
obtained by FMF analysis of an un-
separated tumour-cell suspension (USC) and
fractions of cells separated from that sus-
pension bycentrifugal elutriation (F2 - F1o)
following in vivo exposure to 3 doses ofHU.
evident for FSa cells collected in elutriator
F 4-10. Tumour cells in the first 3
fractions, however, had a significantly
reduced CFE, even after correction for
normal cell contamination. The modal
volume for cells in each of these fractions
was <800 jUm3. The reduced CFE of
these populations is consistent with results
published in an earlier report on the
reduced CFE of small (i.e., < 800 iUM3)
FSa cells from solid tumours (Grdina
et al., 1978b). This may reflect a reduced
intrinsic proliferative ability of these
cells or a less efficient retention of cells
in the lungs. However, in similar studies
with L-P59 sarcoma cells assayed in vitro,
the smallest tumour cells had significantly
low CFE, suggesting that small tumour
cells (i.e., < 800 ium3) separated by
centrifugal elutriation are intrinsically
the least clonogenic (Meistrich et al.,
1.977).
Because FSa cells were separated from
tumour nodules growing in murine lung
tissue, tumour cell suspensions were
always contaminated by normal diploid
lung cells. Attempts to extract individual
lung nodules before the preparation of cell
suspensions in order to reduce this
contamination substantially were unsuc-
cessful. After centrifugal elutriation, how-
ever, 65-85% of the normal diploid cells
in the initial cell suspension, as determined
by FMF analysis, were routinely collected
in the first 3 fractions. This procedure
may therefore prove to be an effective
means of enriching the proportion of
TABLE II.-Distribution of HU-Treated (3/1/mg/g) cells in various phases of the cell cycle
after centrifugal elutriation (Determined by FMIF analysis)
% Cells in
G2+M(T) CV of Gl(T) peak
5 6-2
0 5-7
3 6-0
5 5-2
3 5-3
8 5-8
14 7-4
15 6-3
16 7-1
17 8-0
60
40
2-0
60
40
20
'-
60
-J w
Z 40 z
X 20
C') cn
- 60
w 60
Fraction
number
USC
2
3
4
5
6
7
8
9
10
G1(N)
36
71
59
13
14
15
18
22
28
24
G1(T)
73
94
86
84
77
65
52
37
29
17
S(T)
2)
6
11
11
20
27
34
48
55
56
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malignant cells in tumour-cell suspensions.
Studies on the effect(s) of host cells on
tumour growth and kinetics might be
facilitated in this way.
FSa cells, synchronized by centrifugal
elutriation following growth as pulmon-
ary nodules and injected into recipient
mice (i.e., Procedure A), responded to a
single i.p. dose of HU in a manner
similar to that described for FSa cells
separated from exponential cultures
(Grdina et al., 1979). HU was administered
20 min after tumour-cell injection in
this procedure, because at this time
> 950o of the injected cells are retained
in the lungs (Grdina et al., 1978b). As
described in an earlier report, cell killing
by HU was strongly correlated with the
percentage of cells in S phase, as deter-
mined by FMF analysis (Fig. 4).
The use of Procedure A for assessing
the cycle-dependence of cytotoxic agents
in vivo is predicated upon direct cell
killing of target tumour cells. A phe-
nomenonthat couldprecludetheusefulness
of this method would be a drug-mediated
effect on the host response to the injected
tumour cells that might selectively (i.e.,
as a function of their position within the
division cycle), affect their clonogenic
capacity. Two extremely effective agents
that are known to enhance CFE ofinjected
tumour cells are radiation and cyclo-
phosphamide. However, using mice pre-
conditioned with either of these agents,
both lung-retention patterns of 1251-
labelled FSa cells and the CFE of un-
labelled cells were found not to vary with
either cell size or position within the
division cycle (Grdina et al., 1 978b).
Thus, under these conditions Procedure A
remains an effective method for character-
izing the relative in vivo phase specificity
of cytotoxic agents such as HU. The
usefulness of this procedure is confirmed
by the close agreement between data
acquired in this manner and those
derived from established in vitro methods
(Grdina et al., 1980; Mehn et al., 1980).
The S-phase-specific cytotoxicity of
HU to FSa cells was also demonstrable
after in situ treatment of 1 3-day-old
tumour lung nodules (i.e., Procedure B;
Fig. 6). Cell killing was again correlated
with the fraction of cells in S phase.
No reduction in cell recovery was evident,
either in the preparation ofcell suspensions
or by centrifugal elutriation. Because the
treatment time exceeded the duration
of G2 +M (Grdina, 1982) it was not
surprising that the proportion of cells in
this phase was diminished. FMF analysis
was made difficult, however, by the
bimodal nature of the fluorescence peaks
describing the DNA distributions of the
tumour populations (Fig. 6). This hetero-
geneity may have been due to a differential
effect of HU on either the progression
and killing and/or the stainability by
mithramycin of cells in at least 2
distinct classes (i.e., with respect to
DNA content) of FSa cells. Because ofthe
relatively short exposure, it is unlikely
that HU altered the DNA content of
FSa cells. Rather, it is more likely that
HU acted somehow to affect the staina-
bility of a class of FSa cells by mithra-
mycin. This phenomenon has been des-
cribed in Chinese hamster ovary (cells
treated with bromodeoxyuridine(Swart-
zendruber, 1977). It is also interesting that
the fluorescence peak describing the
normal-diploid cells from each elutriator
fraction wasnot affected by this treatment.
In conclusion, the phase-specific cyto-
toxicity of HU, administered in either a
single- or multiple-dose schedule, on
FSa cells from pulmonary nodules was
described. In addition to measuring cyto-
toxicity, this procedure can be used to
monitor and characterize perturbations
in cell kinetics, both during and after
therapeutic treatment. Target tumour
systems can be single cells lodged in the
lungs as well as pulmonary nodules of
various ages and sizes. In this manner,
various therapeutic modalities used either
alone or in combination can be routinely
and rapidly tested and characterized
under in vivo conditions.
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